TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 17350190

Group type: EXPERIMENTAL
Intervention: Perimenopausal health education intervention
Number of subjects: 335

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 335
Study: 15635606

Group type: EXPERIMENTAL
Intervention: Nasal continuous positive airways pressure (CPAP) for 24 hours
Number of subjects: 97

Group type: COMPARATOR
Intervention: Headbox oxygen
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Nasal continuous positive airways pressure (CPAP)
Number of subjects: 97
Study: 12150176

Group type: EXPERIMENTAL
Intervention: EMLA patch
Number of subjects: 165

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 165
Study: 9860036

Group type: EXPERIMENTAL
Intervention: Mometasone furoate 200 microg once daily
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 8589159

Group type: EXPERIMENTAL
Intervention: Cefixime (8 mg/[kg.d]; maximum 400 mg) once a day for 4 days
Number of subjects: 131

Group type: COMPARATOR
Intervention: Rifampin (20 mg/kg; maximum, 600 mg) once a day for 4 days
Number of subjects: 131
Study: 2283715

Group type: EXPERIMENTAL
Intervention: Cefdinir granules at a dose of 3 mg/kg
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Cefdinir granules at a dose of 6 mg/kg
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Cefdinir granules at daily doses of 9.0‐20.7 mg/kg in 3 divided portions
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Cefdinir granules
Number of subjects: 42
Study: 10249191

Group type: EXPERIMENTAL
Intervention: Educational intervention in the form of a mothers' group discussion led by the clinic social worker
Number of subjects: 201

Group type: COMPARATOR
Intervention: Control group (no educational intervention)
Number of subjects: 201
Study: 31768618

Group type: EXPERIMENTAL
Intervention: Chin tuck against resistance (CTAR)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Chin tuck exercise with theraband
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Shaker exercises
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 36
Study: 31510721

Group type: COMPARATOR
Intervention: Bilateral PC6 sham injection of 0.9% sodium chloride + intravenous granisetron (Group A, n=31)
Number of subjects: 94

Group type: COMPARATOR
Intervention: Bilateral acupuncture point injection at PC6 of 0.9% sodium chloride + intravenous 0.9% sodium chloride (Group B, n=33)
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Bilateral acupuncture point injection at PC6 of 0.9% sodium chloride + intravenous granisetron (Group C, n=30)
Number of subjects: 94

Group type: COMPARATOR
Intervention: Comparison of motilin concentration after 12 hours in all groups
Number of subjects: 94

Group type: COMPARATOR
Intervention: Comparison of time for first anal exsufflation in all groups
Number of subjects: 94
Study: 28266871

Group type: EXPERIMENTAL
Intervention: Deep Dry Needling (DDN)
Number of subjects: 133

Group type: COMPARATOR
Intervention: Manual Palpation (MPal)
Number of subjects: 133
Study: 25890480

Group type: EXPERIMENTAL
Intervention: Cellular immunotherapy (CIT) with autologous natural killer cells, γδT cells, and cytokine‐induced killer cells in combination with chemotherapy
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Cellular immunotherapy (CIT) with chemotherapy
Number of subjects: 58

Group type: COMPARATOR
Intervention: Chemotherapy alone
Number of subjects: 58
Study: 23487517

Group type: EXPERIMENTAL
Intervention: Betrixaban 40 mg once daily
Number of subjects: 508

Group type: EXPERIMENTAL
Intervention: Betrixaban 60 mg once daily
Number of subjects: 508

Group type: EXPERIMENTAL
Intervention: Betrixaban 80 mg once daily
Number of subjects: 508

Group type: COMPARATOR
Intervention: Warfarin (adjusted to INR 2.0-3.0)
Number of subjects: 508
Study: 21328090

Group type: EXPERIMENTAL
Intervention: Medically managed withdrawal
Number of subjects: 344
Study: 19414675

Group type: EXPERIMENTAL
Intervention: mitumprotimut-T/GM-CSF
Number of subjects: 349

Group type: COMPARATOR
Intervention: placebo/GM-CSF
Number of subjects: 349
Study: 17049237

Group type: EXPERIMENTAL
Intervention: Fatigue of hip movers (frontal and sagittal planes)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Fatigue of frontal movers
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Fatigue of lower extremity muscle groups (ankle plantar/dorsi flexors, ankle evertor/invertors, hip flexor/extensors, hip abductor/adductors)
Number of subjects: 20
Study: 15119683

Group type: EXPERIMENTAL
Intervention: Palatal mucosal grafts
Number of subjects: 0

Group type: COMPARATOR
Intervention: Dura mater grafts
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fascia lata grafts
Number of subjects: 0
Study: 11436934

Group type: EXPERIMENTAL
Intervention: Clinic-only intervention
Number of subjects: 335

Group type: EXPERIMENTAL
Intervention: Clinic plus a school-as-community (SAC) component
Number of subjects: 335

Group type: COMPARATOR
Intervention: Standard care control
Number of subjects: 335
Study: 9596465

Group type: EXPERIMENTAL
Intervention: Dictation in the presence of the patient
Number of subjects: 120

Group type: COMPARATOR
Intervention: Standard visit control group
Number of subjects: 120
Study: 8191242

Group type: EXPERIMENTAL
Intervention: Cefpodoxime proxetil 100 mg bid for 5 days (n = 113)
Number of subjects: 220

Group type: COMPARATOR
Intervention: Phenoxymethyl penicillin 600 mg tid for 10 days (n = 107)
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Cefpodoxime proxetil
Number of subjects: 220

Group type: COMPARATOR
Intervention: Phenoxymethyl penicillin
Number of subjects: 220
Study: 3312761

Group type: EXPERIMENTAL
Intervention: Hypertonic hemodiafiltration (H HDF)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Hemodialysis (HD)
Number of subjects: 10
Study: 29793869

Group type: EXPERIMENTAL
Intervention: BMI ≥85th percentile (overweight or obese)
Number of subjects: 388

Group type: EXPERIMENTAL
Intervention: BMI ≥95th percentile (obese)
Number of subjects: 388

Group type: EXPERIMENTAL
Intervention: Higher body fat (subscapular skinfold and triceps skinfold >85th percentile)
Number of subjects: 388

Group type: EXPERIMENTAL
Intervention: Central fat (waist circumference >90th percentile)
Number of subjects: 388

Group type: EXPERIMENTAL
Intervention: Sedentary activity levels
Number of subjects: 388

Group type: EXPERIMENTAL
Intervention: Systolic and/or diastolic hypertension
Number of subjects: 388

Group type: EXPERIMENTAL
Intervention: Postdischarge weight gain velocities from 36 weeks postmenstrual age to 18 months
Number of subjects: 388

Group type: EXPERIMENTAL
Intervention: Weight gain velocity from 18 months to 6‐7 years
Number of subjects: 388
Study: 27780285

Group type: EXPERIMENTAL
Intervention: Single bundle all‐inside arthroscopic inlay
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Single bundle all‐inside suspensory fixation
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Single bundle arthroscopic‐assisted open onlay (SB‐ONL)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Double bundle arthroscopic‐assisted open inlay (DB‐INL)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Double bundle all‐inside suspensory fixation (DB‐SUSP)
Number of subjects: 20

Group type: COMPARATOR
Intervention: PCL intact
Number of subjects: 20
Study: 26156743

Group type: EXPERIMENTAL
Intervention: Dietary folate intake (tertile 3 compared with tertile 1)
Number of subjects: 5880

Group type: EXPERIMENTAL
Intervention: Erythrocyte folate concentration (tertile 3 compared with tertile 1)
Number of subjects: 5880
Study: 23117470

Group type: EXPERIMENTAL
Intervention: Potassium-iron-phosphate-citrate complex
Number of subjects: 51

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51
Study: 20884982

Group type: EXPERIMENTAL
Intervention: Cemented hemiarthroplasty (137 patients)
Number of subjects: 252

Group type: COMPARATOR
Intervention: Cemented total hip replacement (THR) (115 patients)
Number of subjects: 252
Study: 18579449

Group type: EXPERIMENTAL
Intervention: RCTs that mentioned 'randomization' in the title or abstract
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: RCTs that described the method to generate the random sequence
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: RCTs with adequate allocation concealment
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: RCTs that mentioned 'masking'
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: High-quality RCTs as assessed by the Jadad scale
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: Overall reporting quality of RCTs
Number of subjects: 142
Study: 15699226

Group type: EXPERIMENTAL
Intervention: Eating Breakfast (EB)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Omitting Breakfast (OB)
Number of subjects: 10
Study: 12855349

Group type: EXPERIMENTAL
Intervention: EMLA cream and oral glucose (1 ml of glucose at 300 mg/ml)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: EMLA cream and oral glucose
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo cream and water
Number of subjects: 90
Study: 10100592

Group type: EXPERIMENTAL
Intervention: Granisetron injection (40 microg/kg) via 30-min infusion
Number of subjects: 93

Group type: COMPARATOR
Intervention: Granisetron injection (40 microg/kg) via slow intravenous injection over 30 s
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Granisetron injection (40 microg/kg) via 30-min infusion and slow intravenous injection
Number of subjects: 93
Study: 8739815

Group type: EXPERIMENTAL
Intervention: Supplemental oxygen withheld (hypoxaemia)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Supplemental oxygen administered (normoxaemia)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Hypoxaemia (PaO2 < or = 50 Torr)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Normoxaemia (PaO2 > or = 60 Torr)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Hypoxaemia
Number of subjects: 10

Group type: COMPARATOR
Intervention: Normoxaemia
Number of subjects: 10
Study: 1911498

Group type: EXPERIMENTAL
Intervention: Intravenous lidocaine
Number of subjects: 9

Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 9
Study: 7134874

Group type: EXPERIMENTAL
Intervention: 1:3 jejunoileal bypass
Number of subjects: 34

Group type: COMPARATOR
Intervention: 3:1 jejunoileal bypass
Number of subjects: 34
Study: 30958543

Group type: EXPERIMENTAL
Intervention: sIPV
Number of subjects: 1200

Group type: COMPARATOR
Intervention: IPV
Number of subjects: 1200
Study: 28295143

Group type: EXPERIMENTAL
Intervention: Impaired orthostatic blood pressure recovery (OH(40))
Number of subjects: 4127

Group type: EXPERIMENTAL
Intervention: Orthostatic hypotension (OH)
Number of subjects: 4127

Group type: EXPERIMENTAL
Intervention: Initial orthostatic hypotension (IOH)
Number of subjects: 4127
Study: 26252749

Group type: EXPERIMENTAL
Intervention: Azithromycin 500 mg
Number of subjects: 13

Group type: COMPARATOR
Intervention: Amoxicillin 2 g
Number of subjects: 13
Study: 23718900

Group type: EXPERIMENTAL
Intervention: 30 mg vinorelbine, taken orally three times a week
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: 40 mg vinorelbine, taken orally three times a week
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: 50 mg vinorelbine, taken orally three times a week
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Low pre-treatment blood concentrations of FGF2 and IL8
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: High levels of TEK gene transcript
Number of subjects: 73
Study: 21395901

Group type: EXPERIMENTAL
Intervention: New technique (group 1)
Number of subjects: 175

Group type: COMPARATOR
Intervention: Traditional method (group 2)
Number of subjects: 175
Study: 19411056

Group type: EXPERIMENTAL
Intervention: Nutrition education and gardening (NE+G)
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Nutrition education only (NE)
Number of subjects: 115

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 115
Study: 17539707

Group type: EXPERIMENTAL
Intervention: Photodynamic therapy (PDT) using a laser source with a wavelength of 690 nm associated with a phenothiazine photosensitizer
Number of subjects: 10

Group type: COMPARATOR
Intervention: Scaling and root planing (SRP) with hand instruments
Number of subjects: 10
Study: 15458995

Group type: EXPERIMENTAL
Intervention: Depression information website (BluePages)
Number of subjects: 525

Group type: EXPERIMENTAL
Intervention: Cognitive‐behavioural skills training website (MoodGYM)
Number of subjects: 525

Group type: COMPARATOR
Intervention: Attention control condition
Number of subjects: 525
Study: 11596587

Group type: COMPARATOR
Intervention: Medical treatment
Number of subjects: 198

Group type: EXPERIMENTAL
Intervention: Carotid endarterectomy
Number of subjects: 198
Study: 10063958

Group type: EXPERIMENTAL
Intervention: Case management (1994)
Number of subjects: 280

Group type: COMPARATOR
Intervention: No case management (1990)
Number of subjects: 280
Study: 7917929

Group type: EXPERIMENTAL
Intervention: Tamoxifen, 20 mg daily
Number of subjects: 254

Group type: COMPARATOR
Intervention: Tamoxifen and prednisolone, 7.5 mg daily
Number of subjects: 254
Study: 3395544

Group type: EXPERIMENTAL
Intervention: 0.125% bupivacaine
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 31978933

Group type: EXPERIMENTAL
Intervention: MDMA (0.75, 1.5 mg/kg)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin (20 IU)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study: 31002539

Group type: EXPERIMENTAL
Intervention: Crisaborole
Number of subjects: 0

Group type: COMPARATOR
Intervention: Topical corticosteroids
Number of subjects: 0

Group type: COMPARATOR
Intervention: Tacrolimus
Number of subjects: 0
Study: 28263288

Group type: EXPERIMENTAL
Intervention: Adjuvanted influenza vaccine (MF59)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Non-adjuvanted influenza vaccine
Number of subjects: 73
Study: 26814087

Group type: EXPERIMENTAL
Intervention: NI15 combined with 30% ASIR
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: NI25 combined with 40% ASIR
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: NI30 combined with 50% ASIR
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: NI35 combined with 60% ASIR
Number of subjects: 200

Group type: COMPARATOR
Intervention: Standard dose group (Group A)
Number of subjects: 200
Study: 22575988

Group type: EXPERIMENTAL
Intervention: ivabradine (in patients with heart rate ≥75 bpm)
Number of subjects: 0

Group type: COMPARATOR
Intervention: ivabradine (in patients with heart rate <75 bpm)
Number of subjects: 0
Study: 21527664

Group type: EXPERIMENTAL
Intervention: Resistive vibration exercise (RVE)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 20
Study: 17114331

Group type: EXPERIMENTAL
Intervention: Consider This Internet-based program (Australia)
Number of subjects: 3311

Group type: EXPERIMENTAL
Intervention: Consider This Internet-based program (United States)
Number of subjects: 3311
Study: 16541481

Group type: EXPERIMENTAL
Intervention: Etanercept
Number of subjects: 714
Study: 15071259

Group type: EXPERIMENTAL
Intervention: Anticoagulation Clinic Service (ACS)
Number of subjects: 1165

Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 1165

Group type: COMPARATOR
Intervention: Comparison of ACS vs Usual care
Number of subjects: 1165
Study: 10928667

Group type: EXPERIMENTAL
Intervention: Intraoperative mitomycin-C (0.02%)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Conjunctival autograft
Number of subjects: 37
Study: 8822656

Group type: EXPERIMENTAL
Intervention: High-dose oxytocin (2.5 mU/minute initial dose, increments of 2.5 mU/minute)
Number of subjects: 179

Group type: COMPARATOR
Intervention: Low-dose oxytocin (1.25 mU/minute initial dose, increments of 1.25 mU/minute)
Number of subjects: 179
Study: 1415400

Group type: EXPERIMENTAL
Intervention: One-layer closure with continuous locking No. 1 chromic suture
Number of subjects: 906

Group type: COMPARATOR
Intervention: Two-layer closure with continuous No. 1 chromic suture
Number of subjects: 906

Group type: EXPERIMENTAL
Intervention: One-layer closure
Number of subjects: 906

Group type: COMPARATOR
Intervention: Two-layer closure
Number of subjects: 906
Study: 4061901

Group type: EXPERIMENTAL
Intervention: 0.5 mg/kg lidocaine intravenously
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: 1.0 mg/kg lidocaine intravenously
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: 1.5 mg/kg lidocaine intravenously
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: 2.0 mg/kg lidocaine intravenously
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: 2 mg/kg lidocaine intravenously
Number of subjects: 208

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 208
Study: 31270984

Group type: EXPERIMENTAL
Intervention: MPR CT measurements
Number of subjects: 210

Group type: COMPARATOR
Intervention: Axial measurements
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: MPR diameter
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: 3D measurements
Number of subjects: 210
Study: 28455318

Group type: EXPERIMENTAL
Intervention: Carotid artery stenting (CAS) within 7 days after symptom onset
Number of subjects: 4138

Group type: COMPARATOR
Intervention: Carotid endarterectomy (CEA) within 7 days after symptom onset
Number of subjects: 4138

Group type: EXPERIMENTAL
Intervention: Carotid artery stenting (CAS) after 1 week
Number of subjects: 4138

Group type: COMPARATOR
Intervention: Carotid endarterectomy (CEA) after 1 week
Number of subjects: 4138
Study: 25612603

Group type: EXPERIMENTAL
Intervention: RATG (0.5 mg/kg/day)
Number of subjects: 16

Group type: COMPARATOR
Intervention: RATG plus basiliximab (20 mg on days 0 and 4)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: AZA therapy
Number of subjects: 16

Group type: COMPARATOR
Intervention: MMF therapy
Number of subjects: 16
Study: 24321183

Group type: EXPERIMENTAL
Intervention: Atorvastatin 10 mg/day
Number of subjects: 117

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 117
Study: 21786039

Group type: EXPERIMENTAL
Intervention: Autologous platelet concentrate (APC) added to local autograft plus TCP/HA
Number of subjects: 107

Group type: COMPARATOR
Intervention: Control group without APC addition
Number of subjects: 107
Study: 19160730

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 17524873

Group type: EXPERIMENTAL
Intervention: Oral valgancyclovir for 2 weeks (VAL2w)
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Oral valgancyclovir for 3 months (VAL3m)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Intravenous gancyclovir for 2 weeks (GAN)
Number of subjects: 110
Study: 15337799

Group type: EXPERIMENTAL
Intervention: Oregovomab
Number of subjects: 145

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: Oregovomab (SFLT population)
Number of subjects: 145

Group type: COMPARATOR
Intervention: Placebo (SFLT population)
Number of subjects: 145

Group type: COMPARATOR
Intervention: Oregovomab and Placebo
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: Quality of life
Number of subjects: 145
Study: 12559484

Group type: EXPERIMENTAL
Intervention: COMs
Number of subjects: 66

Group type: COMPARATOR
Intervention: ANXs
Number of subjects: 66

Group type: COMPARATOR
Intervention: NACs
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Men (within COMs)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Women (within COMs)
Number of subjects: 66
Study: 9526931

Group type: EXPERIMENTAL
Intervention: 5 mg oral diazepam
Number of subjects: 202

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 202
Study: 11271312

Group type: EXPERIMENTAL
Intervention: Higher oral FK 506 dose (0.19 mg/kg bw per day) in early phase of multicenter trial
Number of subjects: 267

Group type: COMPARATOR
Intervention: Lower oral FK 506 dose (0.14 mg/kg bw per day) in late phase of multicenter trial
Number of subjects: 267

Group type: COMPARATOR
Intervention: Further reduced FK 506 dosage (0.10 mg/kg bw per day or less) in recent single centre treatment
Number of subjects: 267

Group type: EXPERIMENTAL
Intervention: Patients treated with online FK 506 blood level monitoring
Number of subjects: 267
Study: 2459543

Group type: EXPERIMENTAL
Intervention: Felodipine 1 mg intravenous infusion
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Felodipine 3 mg intravenous infusion
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Felodipine 5 mg oral solution
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Felodipine 15 mg oral solution
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Felodipine 40 mg oral solution
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 15784645

Group type: EXPERIMENTAL
Intervention: Intensive Control (IC)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Conventional Control (CC)
Number of subjects: 19
Study: 31689342

Group type: EXPERIMENTAL
Intervention: Kihon Checklist (KC)
Number of subjects: 243

Group type: EXPERIMENTAL
Intervention: Reported Edmonton Frail Scale (REFS)
Number of subjects: 243

Group type: COMPARATOR
Intervention: Fried's Frailty Phenotype (FP)
Number of subjects: 243

Group type: COMPARATOR
Intervention: Adelaide Frailty Index (AFI)
Number of subjects: 243
Study: 30942007

Group type: EXPERIMENTAL
Intervention: Acupuncture performed within 3 days after onset (Group A)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Oral mecobalamin dispersible tablets and multivitamin B tablets within 3 days after onset, acupuncture started from the 4th day (Group B)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Oral mecobalamin dispersable tablets and multivitamin B tablets within 5 days after onset, acupuncture from the 6th day (Group C)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Oral mecobalamin dispersable tablets and multivitamin B tablets within 7 days after onset, acupuncture from the 8th day (Group D)
Number of subjects: 120
Study: 27053195

Group type: EXPERIMENTAL
Intervention: Participant-selected music to support walking with guidance from a music therapist
Number of subjects: 56

Group type: COMPARATOR
Intervention: Usual care only (Control)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Participant-selected music
Number of subjects: 56
Study: 26852638

Group type: EXPERIMENTAL
Intervention: NMES (neuromuscular electrical stimulation)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control cohort
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: NMES
Number of subjects: 0
Study: 23845716

Group type: EXPERIMENTAL
Intervention: Low-dose computed tomography screening
Number of subjects: 7582

Group type: EXPERIMENTAL
Intervention: Positive baseline screening result
Number of subjects: 7582

Group type: EXPERIMENTAL
Intervention: Indeterminate baseline screening result
Number of subjects: 7582

Group type: EXPERIMENTAL
Intervention: Negative baseline screening result
Number of subjects: 7582